title: Obstetric implications of current Australian product information for thyroid-related medications.
authors.affiliation: Department of Endocrinology and Diabetes, Epworth Hospital, Melbourne, Victoria, Australia. jrs@netspace.net.au
authors.forename: Jim R
authors.initials: JR
authors.lastname: Stockigt
mesh_terms: D013956:Antithyroid Agents / Q000008:administration & dosage; D001315:Australia; D001942:Breast Feeding; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy*; D007037:Hypothyroidism / Q000150:complications / Q000188:drug therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011356:Product Labeling; D013974:Thyroxine / Q000008:administration & dosage
chemical_list: D013956:Antithyroid Agents; D013974:Thyroxine